Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

We evaluated in this study the efficacy and safety of an alternate regimen using clobetasol propionate 0.05% shampoo (CP shampoo) for long-term control of scalp psoriasis. Patients with moderate scalp psoriasis (Global Severity Score [GSS] of 3 on a 0-5 scale) first received CP shampoo once daily for 4 weeks. Patients with a GSS 2) occurred, patients received the 4-week daily CP shampoo treatment. Patients who had a GSS

authors

Vender, Ronald
Poulin, Yves
Papp, Kim
Bissonnette, Robert
Barber, Kirk
Kerrouche, Nabil
Villemagne, Hervé

status

published

publication date

May 1, 2010

has subject area

1103 Clinical Sciences (FoR)
Administration, Cutaneous (MeSH)
Adult (MeSH)
Clobetasol (MeSH)
Dermatology & Venereal Diseases (Science Metrix)
Dose-Response Relationship, Drug (MeSH)
Double-Blind Method (MeSH)
Drug Administration Schedule (MeSH)
Drug-Related Side Effects and Adverse Reactions (MeSH)
Female (MeSH)
Follow-Up Studies (MeSH)
Hair Preparations (MeSH)
Humans (MeSH)
Long-Term Care (MeSH)
Male (MeSH)
Middle Aged (MeSH)
Patient Satisfaction (MeSH)
Probability (MeSH)
Psoriasis (MeSH)
Reference Values (MeSH)
Risk Assessment (MeSH)
Scalp Dermatoses (MeSH)
Severity of Illness Index (MeSH)
Treatment Outcome (MeSH)
Young Adult (MeSH)

published in

Journal of Dermatological Treatment Journal